Advertisement

General Thoracic and Cardiovascular Surgery

, Volume 65, Issue 9, pp 519–526 | Cite as

Histological type predicts mediastinal metastasis and surgical outcome in resected cN1 non-small cell lung cancer

  • Tetsuya MizunoEmail author
  • Takaaki Arimura
  • Hiroaki Kuroda
  • Noriaki Sakakura
  • Yasushi Yatabe
  • Yukinori Sakao
Original Article

Abstract

Objectives

Non-small cell lung cancer (NSCLC) patients at cN1 have unfavorable outcomes. It has been reported that a substantial proportion of cN1 patients have occult mediastinal disease, and treatment guidelines suggest invasive preoperative mediastinal evaluation. However, the population that would most benefit from invasive staging has not been defined. The aims of this study are to identify factors predicting mediastinal metastasis and outcomes in cN1 NSCLC patients to select appropriate candidates for invasive mediastinal evaluation.

Methods

We retrospectively studied 164 patients with radiologically diagnosed cN1 NSCLC. Clinicopathological factors including radiological nodal findings were reviewed. Factors predicting the pN2 status, disease-free survival (DFS), and overall survival (OS) were investigated.

Results

Among 164 patients with cN1 disease, pN2 was diagnosed in 43 (26.4%). This pN2 subgroup included a higher proportion of cases with adenocarcinoma (AD) histology than the pN0/1 subgroup (60.5 vs. 38.8%, p = 0.012). Logistic regression analyses revealed AD as an independent predictor of the pN2 status, while radiological nodal findings were unrelated. Cox regression analyses identified lower preoperative serum CEA, non-AD, and pN0/1 status as favorable factors of DFS and adjuvant therapy to be associated with OS. Five-year DFS was much lower in the pN2 subgroup than the pN0/1 subgroup of AD patients (p < 0.001), while DFS was independent of pN status in non-AD patients.

Conclusions

Adenocarcinoma is predictive of pN2 and poor prognosis in radiologically diagnosed cN1 NSCLC. Accurate mediastinal staging may be more beneficial for prognoses and optimal treatment planning in NSCLC patients with AD histology.

Keywords

cN1 non-small cell lung cancer Occult pN2 Invasive mediastinal staging Adenocarcinoma 

Notes

Compliance with ethical standards

Funding

This study was supported by no specific funding source.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Sawabata N, Miyaoka E, Asamura H, Nakanishi Y, Eguchi K, Mori M, et al. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol. 2011;6(7):1229–35.CrossRefPubMedGoogle Scholar
  2. 2.
    Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch VW, Vansteenkiste JF, et al. The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the n descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(12):1675–84.CrossRefPubMedGoogle Scholar
  3. 3.
    Hishida T, Yoshida J, Nishimura M, Nishiwaki Y, Nagai K. Problems in the current diagnostic standards of clinical n1 non-small cell lung cancer. Thorax. 2008;63(6):526–31.CrossRefPubMedGoogle Scholar
  4. 4.
    Miyoshi K, Mimura T, Iwanaga K, Adachi S, Tsubota N, Okada M. Surgical treatment of clinical n1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis. Surg Today. 2010;40(5):428–32.CrossRefPubMedGoogle Scholar
  5. 5.
    De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(5):787–98.CrossRefGoogle Scholar
  6. 6.
    Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e211S–50S.CrossRefPubMedGoogle Scholar
  7. 7.
    Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568–77.CrossRefPubMedGoogle Scholar
  8. 8.
    Shin S, Kim HK, Choi YS, Kim K, Kim J, Shim YM. Prognosis of unexpected and expected pathologic n1 non-small cell lung cancer. Ann Thorac Surg. 2013;96(3):969–75 (discussion 75–6).CrossRefGoogle Scholar
  9. 9.
    Watanabe S, Asamura H, Suzuki K, Tsuchiya R. Problems in diagnosis and surgical management of clinical n1 non-small cell lung cancer. Ann Thorac Surg. 2005;79(5):1682–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003;123(1 Suppl):137S–46S.CrossRefGoogle Scholar
  11. 11.
    Darling GE, Maziak DE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, et al. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial. J Thorac Oncol. 2011;6(8):1367–72.CrossRefPubMedGoogle Scholar
  12. 12.
    Gu P, Zhao YZ, Jiang LY, Zhang W, Xin Y, Han BH. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer. 2009;45(8):1389–96.CrossRefGoogle Scholar
  13. 13.
    Herth FJ, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest. 2008;133(4):887–91.CrossRefPubMedGoogle Scholar
  14. 14.
    Micames CG, McCrory DC, Pavey DA, Jowell PS, Gress FG. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis. Chest. 2007;131(2):539–48.CrossRefPubMedGoogle Scholar
  15. 15.
    Shingyoji M, Nakajima T, Yoshino M, Yoshida Y, Ashinuma H, Itakura M, et al. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer. Ann Thorac Surg. 2014;98(5):1762–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Dooms C, Tournoy KG, Schuurbiers O, Decaluwe H, De Ryck F, Verhagen A, et al. Endosonography for mediastinal nodal staging of clinical n1 non-small cell lung cancer: a prospective multicenter study. Chest. 2015;147(1):209–15.CrossRefPubMedGoogle Scholar
  17. 17.
    Fukui T, Taniguchi T, Kawaguchi K, Fukumoto K, Nakamura S, Sakao Y, et al. Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma. Gen Thorac Cardiovasc Surg. 2015;63(9):507–13.CrossRefPubMedGoogle Scholar
  18. 18.
    Kawase A, Yoshida J, Ishii G, Nakao M, Aokage K, Hishida T, et al. Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal? Jpn J Clin Oncol. 2012;42(3):189–95.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Association for Thoracic Surgery 2017

Authors and Affiliations

  • Tetsuya Mizuno
    • 1
    Email author
  • Takaaki Arimura
    • 1
  • Hiroaki Kuroda
    • 1
  • Noriaki Sakakura
    • 1
  • Yasushi Yatabe
    • 2
  • Yukinori Sakao
    • 1
  1. 1.Division of Thoracic SurgeryAichi Cancer Center HospitalNagoyaJapan
  2. 2.Division of Pathology and Molecular DiagnosticsAichi Cancer Center HospitalNagoyaJapan

Personalised recommendations